Sec Form 4 Filing - MILCHOVICH RAYMOND J @ DOW CHEMICAL CO /DE/ - 2017-08-31

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
MILCHOVICH RAYMOND J
2. Issuer Name and Ticker or Trading Symbol
DOW CHEMICAL CO /DE/ [ DOW]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director _____ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
2030 DOW CENTER
3. Date of Earliest Transaction (MM/DD/YY)
08/31/2017
(Street)
MIDLAND, MI48674
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common 08/31/2017 D( 1 ) 13,790.4071 D $ 0 ( 1 ) 0 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Appreciation Right payable 2018 (2018 SAR) ( 2 ) $ 50.42 08/31/2017 D( 1 ) 198,334 ( 3 ) ( 3 ) Common 198,334 ( 4 ) 0 D
Stock Appreciation Right payable 2020 (2020 SAR) ( 2 ) $ 50.42 08/31/2017 D( 1 ) 198,334 ( 5 ) ( 5 ) Common 198,334 ( 6 ) 0 D
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
MILCHOVICH RAYMOND J
2030 DOW CENTER
MIDLAND, MI48674
X
Signatures
/s/ Raymond J Milchovich 09/05/2017
Signature of Reporting Person Date
Explanation of Responses:
( 1 )Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.
( 2 )Pursuant to an agreement between the Reporting Person and Third Point LLC, the Reporting Person received a stock appreciation right payable in 2018 and a stock appreciation right payable in 2020 subject to continued service as a director by the Reporting Person on the applicable vesting date, subject to certain exceptions.
( 3 )The 2018 SAR vests as follows: 50% on January 1, 2017 and 50% on January 1, 2018. The 2018 SAR will be settled in cash by Third Point LLC within 30 days following January 1, 2018.
( 4 )As a result of the Merger, the appreciation amount will be based upon the difference between $50.42 and the volume weighted average price of the DowDuPont Common Stock during the 30 day period prior to January 1, 2018, in the case of the 2018 SAR and January 1, 2020, in the case of the 2020 SAR.
( 5 )The 2020 SAR vests as follows: 50% on January 1, 2019 and 50% on January 1, 2020. The 2020 SAR will be settled in cash by Third Point LLC within 30 days following January 1, 2020.
( 6 )As a result of the Merger, the appreciation amount payable by Third Point LLC, if any, will be based upon the difference between $50.42 and the volume weighted average price of the DowDuPont Common Stock during the 30 day period prior to January 1, 2018, in the case of the 2018 SAR and January 1, 2020, in the case of the 2020 SAR.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.